{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:38:44Z","timestamp":1790995124714,"version":"4.1.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["R01MH122869"],"award-info":[{"award-number":["R01MH122869"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["R01HD111117"],"award-info":[{"award-number":["R01HD111117"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40263-025-01202-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:42:34Z","timestamp":1751377354000},"page":"763-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Management of Bipolar Disorder in Pregnancy and Postpartum: A Clinicians\u2019 Guide"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4495-4762","authenticated-orcid":false,"given":"Veerle","family":"Bergink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-8843","authenticated-orcid":false,"given":"Mariella","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-9368","authenticated-orcid":false,"given":"Mary-Anne","family":"Hennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-2555","authenticated-orcid":false,"given":"Thalia","family":"Robakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1202_CR1","volume-title":"American Psychiatric Association Publishing. Textbook of women's reproductive mental health","author":"LA Hutner","year":"2022","unstructured":"Hutner LA, Catapano LA, Nagle-Yang SM, Williams KE, Osborne LM. American Psychiatric Association Publishing. Textbook of women\u2019s reproductive mental health. Washington, DC: American Psychiatric Association Publishing; 2022."},{"issue":"5","key":"1202_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/JCP.0000000000001740","volume":"43","author":"F Uguz","year":"2023","unstructured":"Uguz F, Sharma V, Boyce P, Clark CT, Galbally M, Koukopoulos A, et al. Prophylactic management of women with bipolar disorder during pregnancy and the perinatal period: clinical scenario-based practical recommendations from a group of perinatal psychiatry authors. J Clin Psychopharmacol. 2023;43(5):434\u201352.","journal-title":"J Clin Psychopharmacol"},{"key":"1202_CR3","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-024-00987-2","author":"SN Vigod","year":"2025","unstructured":"Vigod SN, Babujee A, Huang A, Fung K, Vercammen K, Lye J, et al. Perinatal mental illness in Ontario (2007\u20132021): a population-based repeated cross-sectional surveillance study. Can J Public Health. 2025. https:\/\/doi.org\/10.17269\/s41997-024-00987-2.","journal-title":"Can J Public Health"},{"issue":"6","key":"1202_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1176\/appi.ajp.2012.11071047","volume":"169","author":"V Bergink","year":"2012","unstructured":"Bergink V, Bouvy PF, Vervoort JS, Koorengevel KM, Steegers EA, Kushner SA. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry. 2012;169(6):609\u201315.","journal-title":"Am J Psychiatry"},{"key":"1202_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jad.2015.02.033","volume":"178","author":"E Marengo","year":"2015","unstructured":"Marengo E, Martino DJ, Igoa A, Sc\u00e1pola M, Fassi G, Baamonde MU, et al. Unplanned pregnancies and reproductive health among women with bipolar disorder. J Affect Disord. 2015;178:201\u20135.","journal-title":"J Affect Disord"},{"issue":"6","key":"1202_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S2215-0366(24)00093-2","volume":"11","author":"C Dolman","year":"2024","unstructured":"Dolman C, Howard L, Goodwin GM, Young A, Jones IR, Bergink V, et al. Hypersexuality in bipolar disorder: an overlooked symptom. Lancet Psychiatry. 2024;11(6):405\u20136.","journal-title":"Lancet Psychiatry"},{"issue":"4 Suppl","key":"1202_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1359786806066054","volume":"20","author":"CL DeVane","year":"2006","unstructured":"DeVane CL, Stowe ZN, Donovan JL, Newport DJ, Pennell PB, Ritchie JC, et al. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. J Psychopharmacol. 2006;20(4 Suppl):54\u20139.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"1202_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","volume":"192","author":"TS Tracy","year":"2005","unstructured":"Tracy TS, Venkataramanan R, Glover DD, Caritis SN. National Institute for Child H, Human Development Network of Maternal-Fetal-Medicine U. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol. 2005;192(2):633\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1202_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/archgenpsychiatry.2008.528","volume":"66","author":"T Munk-Olsen","year":"2009","unstructured":"Munk-Olsen T, Laursen TM, Mendelson T, Pedersen CB, Mors O, Mortensen PB. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry. 2009;66(2):189\u201395.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1202_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1192\/bjp.2018.92","volume":"213","author":"A Di Florio","year":"2018","unstructured":"Di Florio A, Gordon-Smith K, Forty L, Kosorok MR, Fraser C, Perry A, et al. Stratification of the risk of bipolar disorder recurrences in pregnancy and postpartum. Br J Psychiatry. 2018;213(3):542\u20137.","journal-title":"Br J Psychiatry"},{"issue":"100","key":"1202_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jad.2013.09.034","volume":"152\u2013154","author":"A Di Florio","year":"2014","unstructured":"Di Florio A, Jones L, Forty L, Gordon-Smith K, Blackmore ER, Heron J, et al. Mood disorders and parity\u2014a clue to the aetiology of the postpartum trigger. J Affect Disord. 2014;152\u2013154(100):334\u20139.","journal-title":"J Affect Disord"},{"issue":"2","key":"1202_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1176\/appi.ajp.157.2.179","volume":"157","author":"AC Viguera","year":"2000","unstructured":"Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157(2):179\u201384.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"1202_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","volume":"164","author":"AC Viguera","year":"2007","unstructured":"Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817\u201324 (quiz 923).","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1202_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.eurpsy.2011.06.011","volume":"27","author":"K Doyle","year":"2012","unstructured":"Doyle K, Heron J, Berrisford G, Whitmore J, Jones L, Wainscott G, et al. The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse. Eur Psychiatry. 2012;27(8):563\u20139.","journal-title":"Eur Psychiatry"},{"key":"1202_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jad.2021.08.006","volume":"295","author":"J Gilden","year":"2021","unstructured":"Gilden J, Poels EMP, Lambrichts S, Vreeker A, Boks MPM, Ophoff RA, et al. Bipolar episodes after reproductive events in women with bipolar I disorder, a study of 919 pregnancies. J Affect Disord. 2021;295:72\u20139.","journal-title":"J Affect Disord"},{"issue":"2","key":"1202_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.2015.15010124","volume":"173","author":"R Wesseloo","year":"2016","unstructured":"Wesseloo R, Kamperman AM, Munk-Olsen T, Pop VJ, Kushner SA, Bergink V. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016;173(2):117\u201327.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1202_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamapsychiatry.2023.0041","volume":"80","author":"NTH Trinh","year":"2023","unstructured":"Trinh NTH, Munk-Olsen T, Wray NR, Bergink V, Nordeng HME, Lupattelli A, et al. Timing of antidepressant discontinuation during pregnancy and postpartum psychiatric outcomes in Denmark and Norway. JAMA Psychiat. 2023;80(5):441\u201350.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"1202_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003895","volume":"19","author":"X Liu","year":"2022","unstructured":"Liu X, Molenaar N, Agerbo E, Momen NC, Rommel AS, Lupattelli A, et al. Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: a population-based propensity score-matched cohort study. PLoS Med. 2022;19(1): e1003895.","journal-title":"PLoS Med"},{"issue":"9","key":"1202_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2215-0366(19)30092-6","volume":"6","author":"V Sharma","year":"2019","unstructured":"Sharma V, Bergink V, Berk M, Chandra PS, Munk-Olsen T, Viguera AC, et al. Childbirth and prevention of bipolar disorder: an opportunity for change. Lancet Psychiatry. 2019;6(9):786\u201392.","journal-title":"Lancet Psychiatry"},{"issue":"14","key":"1202_CR20","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.3390\/jcm11143979","volume":"11","author":"J Conejo-Galindo","year":"2022","unstructured":"Conejo-Galindo J, Sanz-Giancola A, \u00c1lvarez-Mon M, Ortega M, Guti\u00e9rrez-Rojas L, Lahera G. Postpartum relapse in patients with bipolar disorder. J Clin Med. 2022;11(14):3979.","journal-title":"J Clin Med"},{"issue":"12","key":"1202_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1176\/appi.ajp.2016.16040454","volume":"173","author":"V Bergink","year":"2016","unstructured":"Bergink V, Rasgon N, Wisner KL. Postpartum psychosis: madness, mania, and melancholia in motherhood. Am J Psychiatry. 2016;173(12):1179\u201388.","journal-title":"Am J Psychiatry"},{"key":"1202_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.euroneuro.2024.02.004","volume":"81","author":"V Bergink","year":"2024","unstructured":"Bergink V. Choosing lithium in the perinatal period, lower dose in the first trimester of pregnancy. Eur Neuropsychopharmacol. 2024;81:66.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"1202_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ogc.2018.04.003","volume":"45","author":"AK Wilkerson","year":"2018","unstructured":"Wilkerson AK, Uhde TW. Perinatal sleep problems: causes, complications, and management. Obstet Gynecol Clin North Am. 2018;45(3):483\u201394.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"1202_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.sleh.2019.03.005","volume":"5","author":"LM Christian","year":"2019","unstructured":"Christian LM, Carroll JE, Porter K, Hall MH. Sleep quality across pregnancy and postpartum: effects of parity and race. Sleep Health. 2019;5(4):327\u201334.","journal-title":"Sleep Health"},{"issue":"3","key":"1202_CR25","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.biopsych.2022.03.006","volume":"92","author":"N Leistikow","year":"2022","unstructured":"Leistikow N, Baller EB, Bradshaw PJ, Riddle JN, Ross DA, Osborne LM. Prescribing sleep: an overlooked treatment for postpartum depression. Biol Psychiatry. 2022;92(3):e13\u20135.","journal-title":"Biol Psychiatry"},{"key":"1202_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jad.2023.11.005","volume":"346","author":"A Perry","year":"2024","unstructured":"Perry A, Gordon-Smith K, Lewis KJS, Di Florio A, Craddock N, Jones L, et al. Perinatal sleep disruption and postpartum psychosis in bipolar disorder: findings from the UK BDRN pregnancy study. J Affect Disord. 2024;346:21\u20137.","journal-title":"J Affect Disord"},{"issue":"3","key":"1202_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/AOG.0000000000002132","volume":"130","author":"JN Felder","year":"2017","unstructured":"Felder JN, Baer RJ, Rand L, Jelliffe-Pawlowski LL, Prather AA. Sleep disorder diagnosis during pregnancy and risk of preterm birth. Obstet Gynecol. 2017;130(3):573\u201381.","journal-title":"Obstet Gynecol"},{"key":"1202_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110228","volume":"107","author":"G Schoretsanitis","year":"2021","unstructured":"Schoretsanitis G, Westin AA, Stingl JC, Deligiannidis KM, Paulzen M, Spigset O. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: a systematic review & combined analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107: 110228.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"1202_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/FTD.0000000000000692","volume":"42","author":"G Schoretsanitis","year":"2020","unstructured":"Schoretsanitis G, Westin AA, Deligiannidis KM, Spigset O, Paulzen M. Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: a systematic critical review and combined analysis. Ther Drug Monit. 2020;42(2):245\u201354.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"1202_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.mcna.2019.02.009","volume":"103","author":"JL Payne","year":"2019","unstructured":"Payne JL. Psychopharmacology in pregnancy and breastfeeding. Med Clin North Am. 2019;103(4):629\u201350.","journal-title":"Med Clin North Am"},{"issue":"3","key":"1202_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ogc.2018.05.002","volume":"45","author":"CT Clark","year":"2018","unstructured":"Clark CT, Wisner KL. Treatment of peripartum bipolar disorder. Obstet Gynecol Clin North Am. 2018;45(3):403\u201317.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"1202_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40345-019-0151-2","volume":"7","author":"L Tondo","year":"2019","unstructured":"Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, et al. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 2019;7(1):16.","journal-title":"Int J Bipolar Disord."},{"issue":"1","key":"1202_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40345-018-0135-7","volume":"6","author":"EMP Poels","year":"2018","unstructured":"Poels EMP, Bijma HH, Galbally M, Bergink V. Lithium during pregnancy and after delivery: a review. Int J Bipolar Disord. 2018;6(1):26.","journal-title":"Int J Bipolar Disord."},{"key":"1202_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jad.2019.02.018","volume":"249","author":"A Stevens","year":"2019","unstructured":"Stevens A, Goossens PJJ, Knoppert-van der Klein EAM, Draisma S, Honig A, Kupka RW. Risk of recurrence of mood disorders during pregnancy and the impact of medication: a systematic review. J Affect Disord. 2019;249:96\u2013103.","journal-title":"J Affect Disord"},{"issue":"14","key":"1202_CR35","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","volume":"330","author":"AA Nierenberg","year":"2023","unstructured":"Nierenberg AA, Agustini B, Kohler-Forsberg O, Cusin C, Katz D, Sylvia LG, et al. Diagnosis and treatment of bipolar disorder: a review. JAMA. 2023;330(14):1370\u201380.","journal-title":"JAMA"},{"issue":"8","key":"1202_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S2215-0366(18)30180-9","volume":"5","author":"T Munk-Olsen","year":"2018","unstructured":"Munk-Olsen T, Liu X, Viktorin A, Brown HK, Di Florio A, D\u2019Onofrio BM, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. Lancet Psychiatry. 2018;5(8):644\u201352.","journal-title":"Lancet Psychiatry"},{"issue":"23","key":"1202_CR37","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","volume":"376","author":"E Patorno","year":"2017","unstructured":"Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017;376(23):2245\u201354.","journal-title":"N Engl J Med"},{"issue":"3","key":"1202_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bdi.13133","volume":"24","author":"EMP Poels","year":"2022","unstructured":"Poels EMP, Schrijver L, White TJH, Roza SJ, Zarchev MG, Bijma H, et al. The effect of prenatal lithium exposure on the neuropsychological development of the child. Bipolar Disord. 2022;24(3):310\u20139.","journal-title":"Bipolar Disord"},{"issue":"1","key":"1202_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1192\/bjp.bp.116.192799","volume":"211","author":"R Wesseloo","year":"2017","unstructured":"Wesseloo R, Wierdsma AI, van Kamp IL, Munk-Olsen T, Hoogendijk WJG, Kushner SA, et al. Lithium dosing strategies during pregnancy and the postpartum period. Br J Psychiatry. 2017;211(1):31\u20136.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"1202_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/acps.13663","volume":"149","author":"L Schrijver","year":"2024","unstructured":"Schrijver L, Kamperman AM, Bijma H, van Kamp IL, Wesseloo R, Hoogendijk WJG, et al. Dose response relationship between lithium serum levels during pregnancy and birth outcomes. Acta Psychiatr Scand. 2024;149(4):323\u201331.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1202_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/bdi.12955","volume":"23","author":"NM Molenaar","year":"2021","unstructured":"Molenaar NM, Poels EMP, Robakis T, Wesseloo R, Bergink V. Management of lithium dosing around delivery: an observational study. Bipolar Disord. 2021;23(1):49\u201354.","journal-title":"Bipolar Disord"},{"issue":"11","key":"1202_CR42","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","volume":"162","author":"DJ Newport","year":"2005","unstructured":"Newport DJ, Viguera AC, Beach AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry. 2005;162(11):2162\u201370.","journal-title":"Am J Psychiatry"},{"key":"1202_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jad.2024.08.140","volume":"366","author":"ML Imaz","year":"2024","unstructured":"Imaz ML, Torra M, Langohr K, Arca G, Soy D, Hern\u00e1ndez AS, et al. Peripartum lithium management: early maternal and neonatal outcomes. J Affect Disord. 2024;366:326\u201334.","journal-title":"J Affect Disord"},{"issue":"5","key":"1202_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.12680","volume":"7","author":"NE Smolinski","year":"2024","unstructured":"Smolinski NE, Sarayani A, Thai TN, Jugl S, Ewig CLY, Winterstein AG. Prenatal exposure to valproic acid across various indications for use. JAMA Netw Open. 2024;7(5): e2412680.","journal-title":"JAMA Netw Open"},{"issue":"21","key":"1202_CR45","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","volume":"78","author":"S Hern\u00e1ndez-D\u00edaz","year":"2012","unstructured":"Hern\u00e1ndez-D\u00edaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012;78(21):1692\u20139.","journal-title":"Neurology"},{"issue":"1","key":"1202_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","volume":"28","author":"A Ornoy","year":"2009","unstructured":"Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol. 2009;28(1):1\u201310.","journal-title":"Reprod Toxicol"},{"issue":"4","key":"1202_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cpt.158","volume":"98","author":"M Tanoshima","year":"2015","unstructured":"Tanoshima M, Kobayashi T, Tanoshima R, Beyene J, Koren G, Ito S. Risks of congenital malformations in offspring exposed to valproic acid in utero: a systematic review and cumulative meta-analysis. Clin Pharmacol Ther. 2015;98(4):417\u201341.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"1202_CR48","first-page":"CD010224","volume":"11","author":"J Weston","year":"2016","unstructured":"Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2016;11(11):CD010224.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1202_CR49","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/14740338.4.2.345","volume":"4","author":"R Alsdorf","year":"2005","unstructured":"Alsdorf R, Wyszynski DF. Teratogenicity of sodium valproate. Expert Opin Drug Saf. 2005;4(2):345\u201353.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"1202_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","volume":"98","author":"C Kozma","year":"2001","unstructured":"Kozma C. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet. 2001;98(2):168\u201375.","journal-title":"Am J Med Genet"},{"issue":"9","key":"1202_CR51","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","volume":"85","author":"E Campbell","year":"2014","unstructured":"Campbell E, Kennedy F, Russell A, Smithson WH, Parsons L, Morrison PJ, et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers. J Neurol Neurosurg Psychiatry. 2014;85(9):1029\u201334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1202_CR52","first-page":"7","volume":"7","author":"RA Epstein","year":"2015","unstructured":"Epstein RA, Moore KM, Bobo WV. Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf. 2015;7:7\u201329.","journal-title":"Drug Healthc Patient Saf."},{"issue":"16","key":"1202_CR53","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Gr\u00f8nborg TK, S\u00f8rensen MJ, Schendel D, Parner ET, Pedersen LH, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696\u2013703.","journal-title":"JAMA"},{"issue":"3","key":"1202_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","volume":"12","author":"KJ Meador","year":"2013","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12(3):244\u201352.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1202_CR55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","volume":"84","author":"RL Bromley","year":"2013","unstructured":"Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, Garc\u00eda-Fi\u00f1ana M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84(6):637\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1202_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open. 2017;7(7): e017248.","journal-title":"BMJ Open"},{"key":"1202_CR57","unstructured":"(WHO) WHO. Statement on the risks associated with valproic acid (sodium valproate) in women and girls of childbearing potential: WHO; 2023. www.who.int\/news\/item\/02-05-2023-use-of-valproic-acid-in-women-and-girls-of-childbearing-potential."},{"key":"1202_CR58","unstructured":"FDA. FDA drug safety communication: valproate anti-seizure products contraindicated for migraine prevention in pregnant women due to decreased IQ Scores in exposed children; 2016. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-valproate-anti-seizure-products-contraindicated-migraine-prevention#tabs-1."},{"issue":"4","key":"1202_CR59","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","volume":"161","author":"KA Yonkers","year":"2004","unstructured":"Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161(4):608\u201320.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"1202_CR60","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209279","volume":"102","author":"AM Pack","year":"2024","unstructured":"Pack AM, Oskoui M, Williams Roberson S, Donley DK, French J, Gerard EE, et al. Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM. Neurology. 2024;102(11): e209279.","journal-title":"Neurology"},{"issue":"6","key":"1202_CR61","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","volume":"17","author":"T Tomson","year":"2018","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530\u20138.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1202_CR62","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209175","volume":"102","author":"E Honybun","year":"2024","unstructured":"Honybun E, Cockle E, Malpas CB, O\u2019Brien TJ, Vajda FJ, Perucca P, et al. Neurodevelopmental and functional outcomes following in utero exposure to antiseizure medication: a systematic review. Neurology. 2024;102(8): e209175.","journal-title":"Neurology"},{"issue":"2","key":"1202_CR63","doi-asserted-by":"publisher","first-page":"FSO116","DOI":"10.4155\/fsoa-2015-0015","volume":"2","author":"HN Moussa","year":"2016","unstructured":"Moussa HN, Hosseini Nasab S, Haidar ZA, Blackwell SC, Sibai BM. Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks. Future Sci OA. 2016;2(2):FSO116.","journal-title":"Future Sci OA"},{"key":"1202_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107068","volume":"108","author":"EH Reynolds","year":"2020","unstructured":"Reynolds EH, Green R. Valproate and folate: congenital and developmental risks. Epilepsy Behav. 2020;108: 107068.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"1202_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian network for mood and anxiety treatments (CANMAT) and International society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97\u2013170.","journal-title":"Bipolar Disord"},{"issue":"6","key":"1202_CR66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/0269881116636545","volume":"30","author":"GM Goodwin","year":"2016","unstructured":"Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495\u2013553.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1202_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","volume":"8","author":"SF Kushner","year":"2006","unstructured":"Kushner SF, Khan A, Lane R, Olson WH. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord. 2006;8(1):15\u201327.","journal-title":"Bipolar Disord"},{"issue":"3 Pt 2","key":"1202_CR68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","volume":"2","author":"AC Pande","year":"2000","unstructured":"Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000;2(3 Pt 2):249\u201355.","journal-title":"Bipolar Disord"},{"key":"1202_CR69","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.seizure.2023.01.008","volume":"105","author":"R Knight","year":"2023","unstructured":"Knight R, Craig J, Irwin B, Wittkowski A, Bromley RL. Adaptive behaviour in children exposed to topiramate in the womb: an observational cohort study. Seizure. 2023;105:56\u201364.","journal-title":"Seizure"},{"issue":"7","key":"1202_CR70","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","volume":"79","author":"MH Bjork","year":"2022","unstructured":"Bjork MH, Zoega H, Leinonen MK, Cohen JM, Dreier JW, Furu K, et al. Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability. JAMA Neurol. 2022;79(7):672\u201381.","journal-title":"JAMA Neurol"},{"issue":"4 Suppl","key":"1202_CR71","first-page":"1","volume":"159","author":"PA American","year":"2002","unstructured":"American PA. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1\u201350.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1202_CR72","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","volume":"64","author":"M Cunnington","year":"2005","unstructured":"Cunnington M, Tennis P. International Lamotrigine Pregnancy Registry Scientific Advisory C. Lamotrigine and the risk of malformations in pregnancy. Neurology. 2005;64(6):955\u201360.","journal-title":"Neurology"},{"issue":"18","key":"1202_CR73","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/WNL.0000000000002540","volume":"86","author":"H Dolk","year":"2016","unstructured":"Dolk H, Wang H, Loane M, Morris J, Garne E, Addor MC, et al. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology. 2016;86(18):1716\u201325.","journal-title":"Neurology"},{"issue":"22 Pt 2","key":"1202_CR74","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","volume":"70","author":"LB Holmes","year":"2008","unstructured":"Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology. 2008;70(22 Pt 2):2152\u20138.","journal-title":"Neurology"},{"issue":"2","key":"1202_CR75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","volume":"34","author":"KM Deligiannidis","year":"2014","unstructured":"Deligiannidis KM, Byatt N, Freeman MP. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 2014;34(2):244\u201355.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"1202_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2009.02.011","volume":"85","author":"C Fotopoulou","year":"2009","unstructured":"Fotopoulou C, Kretz R, Bauer S, Schefold JC, Schmitz B, Dudenhausen JW, et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res. 2009;85(1):60\u20134.","journal-title":"Epilepsy Res"},{"issue":"11","key":"1202_CR77","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1176\/appi.ajp.2013.13010006","volume":"170","author":"CT Clark","year":"2013","unstructured":"Clark CT, Klein AM, Perel JM, Helsel J, Wisner KL. Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry. 2013;170(11):1240\u20137.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1202_CR78","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1600-0404.2011.01627.x","volume":"126","author":"A Sabers","year":"2012","unstructured":"Sabers A. Algorithm for lamotrigine dose adjustment before, during, and after pregnancy. Acta Neurol Scand. 2012;126(1):e1-4.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1202_CR79","first-page":"CD005171","volume":"2008","author":"A Vasudev","year":"2008","unstructured":"Vasudev A, Macritchie K, Watson S, Geddes JR, Young AH. Oxcarbazepine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 2008;2008(1):CD005171.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"1202_CR80","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1111\/bcp.15413","volume":"88","author":"F Athar","year":"2022","unstructured":"Athar F, Ehsan M, Farooq M, Lo KB, Cheema HA, Ahmad S, et al. Adverse fetal and neonatal outcomes following in-utero exposure to oxcarbazepine: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(8):3600\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1202_CR81","first-page":"CD010224","volume":"8","author":"R Bromley","year":"2023","unstructured":"Bromley R, Adab N, Bluett-Duncan M, Clayton-Smith J, Christensen J, Edwards K, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2023;8(8):CD010224.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"1202_CR82","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","volume":"8","author":"R Brauer","year":"2021","unstructured":"Brauer R, Alfageh B, Blais JE, Chan EW, Chui CSL, Hayes JF, et al. Psychotropic medicine consumption in 65 countries and regions, 2008\u201319: a longitudinal study. Lancet Psychiatry. 2021;8(12):1071\u201382.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"1202_CR83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/bcpt.14074","volume":"135","author":"H Breivik","year":"2024","unstructured":"Breivik H, Westin AA, Frost J. Doses, serum concentrations and diagnoses of Norwegian quetiapine users 2001\u20132019 in a therapeutic drug monitoring material. Basic Clin Pharmacol Toxicol. 2024;135(4):523\u201333.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"11","key":"1202_CR84","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","volume":"68","author":"Y Park","year":"2017","unstructured":"Park Y, Huybrechts KF, Cohen JM, Bateman BT, Desai RJ, Patorno E, et al. Antipsychotic medication use among publicly insured pregnant women in the United States. Psychiatr Serv. 2017;68(11):1112\u20139.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"1202_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","volume":"16","author":"S Toh","year":"2013","unstructured":"Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, et al. Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S. 2001\u20132007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013;16(2):149\u201357.","journal-title":"Arch Womens Ment Health"},{"issue":"9","key":"1202_CR86","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","volume":"73","author":"KF Huybrechts","year":"2016","unstructured":"Huybrechts KF, Hern\u00e1ndez-D\u00edaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiat. 2016;73(9):938\u201346.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"1202_CR87","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","volume":"80","author":"KF Huybrechts","year":"2023","unstructured":"Huybrechts KF, Straub L, Karlsson P, Pazzagli L, Furu K, Gissler M, et al. Association of in utero antipsychotic medication exposure with risk of congenital malformations in Nordic countries and the US. JAMA Psychiat. 2023;80(2):156\u201366.","journal-title":"JAMA Psychiat"},{"issue":"11","key":"1202_CR88","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1111\/bcp.14839","volume":"87","author":"Z Wang","year":"2021","unstructured":"Wang Z, Brauer R, Man KKC, Alfageh B, Mongkhon P, Wong ICK. Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: a systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(11):4101\u201323.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1202_CR89","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ebmental-2021-300311","volume":"25","author":"\u00d3 H\u00e1lfd\u00e1narson","year":"2022","unstructured":"H\u00e1lfd\u00e1narson \u00d3, Cohen JM, Karlstad \u00d8, Cesta CE, Bj\u00f8rk MH, H\u00e5berg SE, et al. Antipsychotic use in pregnancy and risk of attention\/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Ment Health. 2022;25(2):54\u201362.","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"1202_CR90","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41386-021-01223-y","volume":"47","author":"NC Momen","year":"2022","unstructured":"Momen NC, Robakis T, Liu X, Reichenberg A, Bergink V, Munk-Olsen T. In utero exposure to antipsychotic medication and psychiatric outcomes in the offspring. Neuropsychopharmacology. 2022;47(3):759\u201366.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"1202_CR91","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","volume":"181","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chan AYL, Coghill D, Ip P, Lau WCY, Simonoff E, et al. Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age. JAMA Intern Med. 2021;181(10):1332\u201340.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1202_CR92","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamainternmed.2022.0375","volume":"182","author":"L Straub","year":"2022","unstructured":"Straub L, Hern\u00e1ndez-D\u00edaz S, Bateman BT, Wisner KL, Gray KJ, Pennell PB, et al. Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study. JAMA Intern Med. 2022;182(5):522\u201333.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"1202_CR93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11920-021-01252-w","volume":"23","author":"K Keramatian","year":"2021","unstructured":"Keramatian K, Chakrabarty T, Saraf G, Yatham LN. New developments in the use of atypical antipsychotics in the treatment of bipolar disorder: a systematic review of recent randomized controlled trials. Curr Psychiatry Rep. 2021;23(7):39.","journal-title":"Curr Psychiatry Rep"},{"issue":"11","key":"1202_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160","volume":"13","author":"G Pariente","year":"2016","unstructured":"Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS Med. 2016;13(11): e1002160.","journal-title":"PLoS Med"},{"issue":"3","key":"1202_CR95","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cpt.770","volume":"103","author":"AA Westin","year":"2018","unstructured":"Westin AA, Brekke M, Molden E, Skogvoll E, Castberg I, Spigset O. Treatment with antipsychotics in pregnancy: changes in drug disposition. Clin Pharmacol Ther. 2018;103(3):477\u201384.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"1202_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.190","volume":"6","author":"T Munk-Olsen","year":"2016","unstructured":"Munk-Olsen T, Maegbaek ML, Johannsen BM, Liu X, Howard LM, di Florio A, et al. Perinatal psychiatric episodes: a population-based study on treatment incidence and prevalence. Transl Psychiatry. 2016;6(10): e919.","journal-title":"Transl Psychiatry"},{"issue":"10","key":"1202_CR97","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10654-024-01156-y","volume":"39","author":"K Joseph-Delaffon","year":"2024","unstructured":"Joseph-Delaffon K, Eletri L, Dechartres A, Nordeng HME, Richardson JL, Elefant E, et al. Neonatal outcomes after in utero exposure to antipsychotics: a systematic review and meta-analysis. Eur J Epidemiol. 2024;39(10):1073\u201396.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1202_CR98","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/ajo.12986","volume":"60","author":"M Galbally","year":"2020","unstructured":"Galbally M, Frayne J, Watson SJ, Morgan V, Snellen M. The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: a multicentre study. Aust N Z J Obstet Gynaecol. 2020;60(1):63\u20139.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6","key":"1202_CR99","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1176\/appi.ajp.2018.17040393","volume":"175","author":"Y Park","year":"2018","unstructured":"Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, et al. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry. 2018;175(6):564\u201374.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1202_CR100","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1517\/14740338.6.6.685","volume":"6","author":"SK Gill","year":"2007","unstructured":"Gill SK, Einarson A. The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf. 2007;6(6):685\u201394.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"1202_CR101","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/schbul\/sbn107","volume":"36","author":"S Gentile","year":"2010","unstructured":"Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36(3):518\u201344.","journal-title":"Schizophr Bull"},{"issue":"8","key":"1202_CR102","first-page":"36","volume":"2","author":"MM Iqbal","year":"2005","unstructured":"Iqbal MM, Aneja A, Rahman A, Megna J, Freemont W, Shiplo M, et al. The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation. Psychiatry (Edgmont). 2005;2(8):36\u201344.","journal-title":"Psychiatry (Edgmont)"},{"issue":"8","key":"1202_CR103","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1080\/01443615.2017.1312307","volume":"37","author":"YJ Shin","year":"2017","unstructured":"Shin YJ, Choi JS, Ahn HK, Ryu HM, Kim MY, Han JY. Pregnancy outcomes in women reporting ingestion of levosulpiride in early pregnancy. J Obstet Gynaecol. 2017;37(8):992\u20135.","journal-title":"J Obstet Gynaecol"},{"issue":"8","key":"1202_CR104","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","volume":"164","author":"DJ Newport","year":"2007","unstructured":"Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164(8):1214\u201320.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1202_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00737-016-0670-0","volume":"20","author":"TM Mehta","year":"2017","unstructured":"Mehta TM, Van Lieshout RJ. A review of the safety of clozapine during pregnancy and lactation. Arch Womens Ment Health. 2017;20(1):1\u20139.","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"1202_CR106","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/neurolint14010024","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, Ellis ED, Nussdorf LM, Hill TW, Cornett EM, Kaye AM, et al. Antipsychotic polypharmacy-related cardiovascular morbidity and mortality: a comprehensive review. Neurol Int. 2022;14(1):294\u2013309.","journal-title":"Neurol Int"},{"issue":"4","key":"1202_CR107","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/jwh.2022.0310","volume":"32","author":"LS Cohen","year":"2023","unstructured":"Cohen LS, Church TR, Freeman MP, Gaccione P, Caplin PS, Kobylski LA, et al. Reproductive safety of lurasidone and quetiapine: update from the National Pregnancy Registry for Psychiatric Medications. J Womens Health (Larchmt). 2023;32(4):452\u201362.","journal-title":"J Womens Health (Larchmt)"},{"issue":"16","key":"1202_CR108","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.3390\/ijerph20166565","volume":"20","author":"G Eleftheriou","year":"2023","unstructured":"Eleftheriou G, Zandonella Callegher R, Butera R, De Santis M, Cavaliere AF, Vecchio S, et al. Consensus panel recommendations for the pharmacological management of pregnant women with depressive disorders. Int J Environ Res Public Health. 2023;20(16):6565.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1202_CR109","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","volume":"16","author":"SY Gao","year":"2018","unstructured":"Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018;16(1):205.","journal-title":"BMC Med"},{"issue":"12","key":"1202_CR110","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/1471-0528.16772","volume":"128","author":"L Kolding","year":"2021","unstructured":"Kolding L, Ehrenstein V, Pedersen L, Sandager P, Petersen OB, Uldbjerg N, et al. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG. 2021;128(12):1949\u201357.","journal-title":"BJOG"},{"issue":"3","key":"1202_CR111","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","volume":"44","author":"C De Vries","year":"2021","unstructured":"De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants. Drug Saf. 2021;44(3):291\u2013312.","journal-title":"Drug Saf"},{"issue":"12","key":"1202_CR112","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36639","volume":"4","author":"T Munk-Olsen","year":"2021","unstructured":"Munk-Olsen T, Bergink V, Rommel AS, Momen N, Liu X. Association of persistent pulmonary hypertension in infants with the timing and type of antidepressants in utero. JAMA Netw Open. 2021;4(12): e2136639.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1202_CR113","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/acps.13409","volume":"145","author":"AS Rommel","year":"2022","unstructured":"Rommel AS, Momen NC, Molenaar NM, Agerbo E, Bergink V, Munk-Olsen T, et al. Antidepressant use during pregnancy and risk of adverse neonatal outcomes: a comprehensive investigation of previously identified associations. Acta Psychiatr Scand. 2022;145(6):544\u201356.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1202_CR114","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/acps.13593","volume":"150","author":"TK Robakis","year":"2024","unstructured":"Robakis TK, Miyares S, Bergink V. Risks and benefits of pre-delivery taper in pregnant women taking antidepressants. Acta Psychiatr Scand. 2024;150(5):355\u20139.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"1202_CR115","doi-asserted-by":"publisher","first-page":"19r12965","DOI":"10.4088\/JCP.19r12965","volume":"81","author":"AS Rommel","year":"2020","unstructured":"Rommel AS, Bergink V, Liu X, Munk-Olsen T, Molenaar NM. Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review. J Clin Psychiatry. 2020;81(3):19r12965.","journal-title":"J Clin Psychiatry"},{"key":"1202_CR116","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jad.2017.08.054","volume":"225","author":"KJS Lewis","year":"2018","unstructured":"Lewis KJS, Di Florio A, Forty L, Gordon-Smith K, Perry A, Craddock N, et al. Mania triggered by sleep loss and risk of postpartum psychosis in women with bipolar disorder. J Affect Disord. 2018;225:624\u20139.","journal-title":"J Affect Disord"},{"issue":"4","key":"1202_CR117","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jmwh.12004","volume":"58","author":"PM Nodine","year":"2013","unstructured":"Nodine PM, Matthews EE. Common sleep disorders: management strategies and pregnancy outcomes. J Midwifery Womens Health. 2013;58(4):368\u201377.","journal-title":"J Midwifery Womens Health"},{"issue":"11","key":"1202_CR118","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00787-022-02053-z","volume":"32","author":"K Koutra","year":"2023","unstructured":"Koutra K, Margetaki K, Kampouri M, Kyriklaki A, Roumeliotaki T, Vafeiadi M, et al. Maternal sleep disturbances during late pregnancy and child neuropsychological and behavioral development in early childhood. Eur Child Adolesc Psychiatry. 2023;32(11):2139\u201350.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1202_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.798453","volume":"12","author":"D Xu","year":"2021","unstructured":"Xu D, Cardell E, Broadley SA, Sun J. Efficacy of face-to-face delivered cognitive behavioral therapy in improving health status of patients with insomnia: a meta-analysis. Front Psychiatry. 2021;12: 798453.","journal-title":"Front Psychiatry."},{"issue":"1","key":"1202_CR120","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ogc.2022.10.009","volume":"50","author":"S Lubotzky-Gete","year":"2023","unstructured":"Lubotzky-Gete S, Barker LC, Vigod SN. A clinical review of the use of common psychiatric medications in pregnancy: guidelines for obstetrical providers. Obstet Gynecol Clin North Am. 2023;50(1):219\u201327.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"1202_CR121","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1139\/jpn.0534","volume":"30","author":"LE Ross","year":"2005","unstructured":"Ross LE, Murray BJ, Steiner M. Sleep and perinatal mood disorders: a critical review. J Psychiatry Neurosci. 2005;30(4):247\u201356.","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"1202_CR122","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ajog.2014.10.1106","volume":"212","author":"ML Okun","year":"2015","unstructured":"Okun ML, Ebert R, Saini B. A review of sleep-promoting medications used in pregnancy. Am J Obstet Gynecol. 2015;212(4):428\u201341.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1202_CR123","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/acps.13441","volume":"146","author":"S Grigoriadis","year":"2022","unstructured":"Grigoriadis S, Alibrahim A, Mansfield JK, Sullovey A, Robinson GE. Hypnotic benzodiazepine receptor agonist exposure during pregnancy and the risk of congenital malformations and other adverse pregnancy outcomes: a systematic review and meta-analysis. Acta Psychiatr Scand. 2022;146(4):312\u201324.","journal-title":"Acta Psychiatr Scand"},{"key":"1202_CR124","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jad.2020.03.014","volume":"269","author":"B Bais","year":"2020","unstructured":"Bais B, Molenaar NM, Bijma HH, Hoogendijk WJG, Mulder CL, Luik AI, et al. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis. J Affect Disord. 2020;269:18\u201327.","journal-title":"J Affect Disord"},{"issue":"4","key":"1202_CR125","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.psym.2018.03.009","volume":"59","author":"SK Chaudhry","year":"2018","unstructured":"Chaudhry SK, Susser LC. Considerations in treating insomnia during pregnancy: a literature review. Psychosomatics. 2018;59(4):341\u20138.","journal-title":"Psychosomatics"},{"issue":"6","key":"1202_CR126","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00737-009-0100-7","volume":"12","author":"S Juric","year":"2009","unstructured":"Juric S, Newport DJ, Ritchie JC, Galanti M, Stowe ZN. Zolpidem (Ambien) in pregnancy: placental passage and outcome. Arch Womens Ment Health. 2009;12(6):441\u20136.","journal-title":"Arch Womens Ment Health"},{"issue":"4","key":"1202_CR127","doi-asserted-by":"publisher","first-page":"18r12412","DOI":"10.4088\/JCP.18r12412","volume":"80","author":"S Grigoriadis","year":"2019","unstructured":"Grigoriadis S, Graves L, Peer M, Mamisashvili L, Dennis CL, Vigod SN, et al. Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis. J Clin Psychiatry. 2019;80(4):18r12412.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1202_CR128","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0301-2115(01)00545-0","volume":"101","author":"E Eros","year":"2002","unstructured":"Eros E, Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2002;101(2):147\u201354.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"1202_CR129","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S2215-0366(23)00158-X","volume":"10","author":"WL Huang","year":"2023","unstructured":"Huang WL. Safety of benzodiazepine or Z-hypnotic exposure in early pregnancy. Lancet Psychiatry. 2023;10(7):473\u20134.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1202_CR130","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","volume":"33","author":"E Enato","year":"2011","unstructured":"Enato E, Moretti M, Koren G. The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can. 2011;33(1):46\u20138.","journal-title":"J Obstet Gynaecol Can"},{"key":"1202_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104647","volume":"137","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang T, Ekheden I, Chang Z, Hellner C, Jan H, et al. Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: a systematic review. Neurosci Biobehav Rev. 2022;137: 104647.","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"1202_CR132","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2215-0366(23)00148-7","volume":"10","author":"LC Meng","year":"2023","unstructured":"Meng LC, Lin CW, Lin YC, Huang ST, Chen YY, Shang CY, et al. Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan. Lancet Psychiatry. 2023;10(7):499\u2013508.","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"1202_CR133","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1177\/0706743720904860","volume":"65","author":"S Grigoriadis","year":"2020","unstructured":"Grigoriadis S, Graves L, Peer M, Mamisashvili L, Ruthirakuhan M, Chan P, et al. Pregnancy and delivery outcomes following benzodiazepine exposure: a systematic review and meta-analysis. Can J Psychiatry. 2020;65(12):821\u201334.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"1202_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5847","volume":"33","author":"LC Meng","year":"2024","unstructured":"Meng LC, Lin CW, Chuang HM, Chen YY, Shang CY, Wu CY, et al. Prescription patterns and predisposing factors of benzodiazepine and Z-hypnotic use during pregnancy: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2024;33(6): e5847.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"1202_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003945","volume":"19","author":"Y Noh","year":"2022","unstructured":"Noh Y, Lee H, Choi A, Kwon JS, Choe SA, Chae J, et al. First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: a population-based cohort study in South Korea. PLoS Med. 2022;19(3): e1003945.","journal-title":"PLoS Med"},{"issue":"2","key":"1202_CR136","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/acps.13696","volume":"150","author":"C Andrade","year":"2024","unstructured":"Andrade C, Varadharajan N, Bascarane S, Menon V. Gestational exposure to benzodiazepines or z-hypnotics and neurodevelopmental disorders in offspring: systematic review and meta-analysis. Acta Psychiatr Scand. 2024;150(2):65\u201377.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1202_CR137","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1435","volume":"2","author":"A Lupattelli","year":"2019","unstructured":"Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H. Association of maternal use of benzodiazepines and Z-hypnotics during pregnancy with motor and communication skills and attention-deficit\/hyperactivity disorder symptoms in preschoolers. JAMA Netw Open. 2019;2(4): e191435.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"1202_CR138","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.46889","volume":"5","author":"LM Sundbakk","year":"2022","unstructured":"Sundbakk LM, Gran JM, Wood ME, Handal M, Skurtveit S, Nordeng H. Association of prenatal exposure to benzodiazepines and Z-hypnotics with risk of attention-deficit\/hyperactivity disorder in childhood. JAMA Netw Open. 2022;5(12): e2246889.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1202_CR139","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/bdra.20513","volume":"85","author":"SM Gilboa","year":"2009","unstructured":"Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol. 2009;85(2):137\u201350.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"1202_CR140","doi-asserted-by":"publisher","first-page":"e002166","DOI":"10.1136\/bmjopen-2012-002166","volume":"3","author":"M Reis","year":"2013","unstructured":"Reis M, K\u00e4ll\u00e9n B. Combined use of selective serotonin reuptake inhibitors and sedatives\/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study. BMJ Open. 2013;3(2):e002166.","journal-title":"BMJ Open"},{"issue":"1","key":"1202_CR141","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/bdra.22865","volume":"94","author":"M Anderka","year":"2012","unstructured":"Anderka M, Mitchell AA, Louik C, Werler MM, Hern\u00e1ndez-Diaz S, Rasmussen SA. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94(1):22\u201330.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"1202_CR142","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/bdra.10021","volume":"67","author":"R Brent","year":"2003","unstructured":"Brent R. Bendectin and birth defects: hopefully, the final chapter. Birth Defects Res A Clin Mol Teratol. 2003;67(2):79\u201387.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"1202_CR143","first-page":"1","volume-title":"Emery and Rimoin\u2019s principles and practice of medical genetics","author":"JM Friedman","year":"2013","unstructured":"Friedman JM, Hanson JW. Chapter 36\u2014clinical teratology. In: Rimoin D, Pyeritz R, Korf B, editors. Emery and Rimoin\u2019s principles and practice of medical genetics. 6th ed. Oxford: Academic Press; 2013. p. 1\u201339.","edition":"6"},{"issue":"1","key":"1202_CR144","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2009.02.005","volume":"155","author":"I Nulman","year":"2009","unstructured":"Nulman I, Rovet J, Barrera M, Knittel-Keren D, Feldman BM, Koren G. Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin. J Pediatr. 2009;155(1):45-50 e1-2.","journal-title":"J Pediatr"},{"issue":"2","key":"1202_CR145","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/070674370304800207","volume":"48","author":"A Einarson","year":"2003","unstructured":"Einarson A, Bonari L, Voyer-Lavigne S, Addis A, Matsui D, Johnson Y, et al. A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatry. 2003;48(2):106\u201310.","journal-title":"Can J Psychiatry"},{"issue":"4","key":"1202_CR146","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/070674370905400405","volume":"54","author":"A Einarson","year":"2009","unstructured":"Einarson A, Choi J, Einarson TR, Koren G. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry. 2009;54(4):242\u20136.","journal-title":"Can J Psychiatry"},{"issue":"1","key":"1202_CR147","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/JCP.0000000000001630","volume":"43","author":"K Dao","year":"2023","unstructured":"Dao K, Shechtman S, Diav-Citrin O, George N, Richardson JL, Rollason V, et al. Reproductive safety of trazodone after maternal exposure in early pregnancy: a comparative ENTIS cohort study. J Clin Psychopharmacol. 2023;43(1):12\u20139.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"1202_CR148","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1590\/1516-4446-2021-2156","volume":"44","author":"T Vine","year":"2022","unstructured":"Vine T, Brown GM, Frey BN. Melatonin use during pregnancy and lactation: a scoping review of human studies. Braz J Psychiatry. 2022;44(3):342\u20138.","journal-title":"Braz J Psychiatry"},{"issue":"3","key":"1202_CR149","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.reprotox.2008.03.005","volume":"25","author":"H Tamura","year":"2008","unstructured":"Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, et al. Melatonin and pregnancy in the human. Reprod Toxicol. 2008;25(3):291\u2013303.","journal-title":"Reprod Toxicol"},{"key":"1202_CR150","doi-asserted-by":"publisher","first-page":"108534","DOI":"10.1016\/j.reprotox.2024.108534","volume":"124","author":"RJ Reiter","year":"2024","unstructured":"Reiter RJ, Sharma R, Chuffa LGDA, Zuccari DA, Amaral FG, Cipolla-Neto J. Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome. Reprod Toxicol. 2024;124:108534.","journal-title":"Reprod Toxicol"},{"issue":"9","key":"1202_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003322","volume":"17","author":"E Patorno","year":"2020","unstructured":"Patorno E, Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, et al. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid analytic eXtract dataset. PLoS Med. 2020;17(9): e1003322.","journal-title":"PLoS Med"},{"issue":"3","key":"1202_CR152","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.reprotox.2008.03.001","volume":"25","author":"A Ornoy","year":"2008","unstructured":"Ornoy A, Zvi N, Arnon J, Wajnberg R, Shechtman S, Diav-Citrin O. The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies. Reprod Toxicol. 2008;25(3):388\u20139.","journal-title":"Reprod Toxicol"},{"issue":"4","key":"1202_CR153","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1399-5618.2006.00335.x","volume":"8","author":"V Sharma","year":"2006","unstructured":"Sharma V, Smith A, Mazmanian D. Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Bipolar Disord. 2006;8(4):400\u20134.","journal-title":"Bipolar Disord"}],"updated-by":[{"DOI":"10.1007\/s40263-025-01239-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000}}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01202-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:02:58Z","timestamp":1760684578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01202-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":153,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1202"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01202-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to a retrospective Open Access order.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40263-025-01239-8","URL":"https:\/\/doi.org\/10.1007\/s40263-025-01239-8","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Veerle Bergink and Thalia Robakis are funded by NIMH grants R01MH122869 and R01HD111117.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Veerle Bergink\u2014idea origination, outline creation\/revision, literature search\/data analysis, manuscript drafting, review and editing, and critically revising manuscript. Mariella Suleiman\u2014outline creation\/revision, literature search\/data analysis, manuscript drafting, and review and editing. Mary-Anne Hennen\u2014outline creation\/revision, literature search\/data analysis, manuscript drafting, and review and editing. Thalia Robakis\u2014outline creation\/revision, literature search\/data analysis, manuscript drafting, review and editing, and critically revising manuscript. All authors have read and approved the final version for submission and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}